CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
New Brunswick, New Jersey, United States and 82 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Bronx, New York, United States and 83 other locations
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....
Phase 2
New York, New York, United States and 6 other locations
28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma...
Phase 3
Woodhaven, New York, United States and 121 other locations
The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma...
Phase 4
Riverdale, New Jersey, United States and 18 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Bronx, New York, United States and 122 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Edison, New Jersey, United States and 45 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
New York, New York, United States and 209 other locations
Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...
Phase 3
New York, New York, United States and 79 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Bronx, New York, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal